Accruing evidence indicates that insomnia is prevalent and persistent in early recovery from substance use disorders and may predict relapse. As such, insomnia treatment after abstinence represents an important area for intervention. This article reviews the literature on insomnia predicting new-onset alcohol and substance use disorders, along with evidence for insomnia predicting relapse in recovering populations. Pharmacological and psychological treatment options are presented, and cognitive-behavioral therapy for insomnia applied to recovering populations is described in detail.
From the Department of Psychiatry (KAK), Stanford University School of Medicine, Stanford, CA; Department of Psychiatry (JM, NR), University of California, San Francisco; and San Francisco VA Medical Center (JM, CP, NR), San Francisco, CA.
Send correspondence and reprint requests to Nicholas Rosenlicht, MD, Department of Psychiatry, University of California, San Francisco, or San Francisco VA Medical Center (116C), 4150 Clement St, San Francisco, CA 94121. E-mail: Nicholas.Rosenlicht@ucsf.edu.
The authors declare no conflicts of interest.
Received November 21, 2013
Accepted May 08, 2014